The liquid handling system market size is expected to advance at a CAGR of 4.20% during 2022–2030, to reach USD 6,521 million by 2030. The growth of the market is attributed to the increasing investment by governments and private companies for the development of the healthcare industry.
Pharma companies are also investing to boost their position, which further drives the demand for liquid handling equipment. For instance, in November 2022, Emalex Bioscience announced the completion of a USD 250-million financing round to advance the development of an Investigational New Drug for Tourette syndrome. More than 220 patients are expected to join Emalex's phase III clinical trial for ecopipam, its novel dopamine-1 receptor antagonist.
Automated liquid handling systems are rapidly becoming popular as they have many advantages, including improved accuracy, less sample contamination, and faster processing. Syringes and pipettes, which are the main tools in a liquid handling system, have received more attention during the development of new automatic equipment. Additionally, because electronic pipettes are thought to be more accurate, their usage has grown.
Manufacturers are putting efforts into creating automated liquid handling systems that accommodate greater workloads at smaller budgets. Moreover, since these systems require fewer human inputs, the chances of errors with them are also less.
Liquid handling systems are widely used at diagnostic centers, research organizations, the biotechnology industry, academic institutes, and other places. Among these, the biotechnology industry held the largest share, of around 35%, in 2022, due to the extensive research biotechnology companies across the world are engaged in.
Similarly, diagnostic centers hold a significant share in the market, and they are likely to emerge as the fastest-growing user of automated liquid handling systems in the coming years. It can be attributed to the increasing prevalence of new diseases, which is driving the demand for better treatments. Hence, automated liquid handling systems are being used at diagnostic centers to identify the disease in the early stages.
The APAC liquid handling system market is expected to witness the fastest growth, led by India and China. This is due to the rise in the investment by life sciences companies in this region.
Pharma and biotech companies are collaborating for advancing drug R&D initiatives in the Asia-Pacific region, which will, in turn, drive the demand for liquid handling systems. For instance, in December 2021, Carterra Inc. announced that it has signed an Asia-Pacific and Oceania region distribution agreement with PerkinElmer Inc., for the latter to sell, market, and service Carterra’s high-throughput antibody screening and characterization solutions.
Europe also holds a significant share because of the presence of countries such as Germany, Switzerland, and the U.K., which are key hubs for healthcare R&D in the world. As a result, companies are opening genomics labs in these nations. For instance, in February 2023, the Sampled SMART Lab in Glasgow has begun a project with precision oncology company Guardant Health Inc. to manage samples of blood for a large lung cancer screening study.
Key players in the market are Thermo Fisher Scientific Inc., Eppendorf AG, SPT Labtech Ltd., INTEGRA Biosciences AG, PerkinElmer Inc., Danaher Corporation, Lonza Group Ltd., HiTec Zang GmbH, Bio-Rad Laboratories Inc., and Mettler-Toledo International Inc.